In addition to the angiogenic pathway, factors within the proliferative pathway, such as PDGF and c-Kit, are also likely to contribute to the highly malignant phenotype of STS.[6] Taken together, these findings provide a rationale for proangiogenic and proliferative factors to serve as potential targets for the treatment of STS. Here, KIT is linked to telomere syndrome.